UnknownPhase 2NCT05275647

Efficacy and Safety of Low Energy Shock Wave Plus BotulinumToxin A in Treating Patients With Interstitial Cystitis

Studying Interstitial cystitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Buddhist Tzu Chi General Hospital
Principal Investigator
Hann-Chorng Kuo, M.D.
Department of Urology, Buddhist TzuChi General Hospital
Intervention
BOTOX 100U in normal saline(drug)
Enrollment
75 target
Eligibility
20 years · All sexes
Timeline
2021 – 2024

Study locations (1)

Collaborators

Ministry of Science and Technology, Taiwan · Hualien Tzu Chi General Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05275647 on ClinicalTrials.gov

Other trials for Interstitial cystitis

Additional recruiting or active studies for the same condition.

See all trials for Interstitial cystitis →

← Back to all trials